Genome-wide profiling and predicted significance of post-mortem brain microRNA in Alzheimer's disease

Adriane D Henriques1, Wilcelly Machado-Silva1, Renata E P Leite2

  • 1Federal University of Brasilia (UnB), Brasília, DF, Brazil.

Abstract

Insights

Six microRNAs (miRNAs) are differentially expressed in Alzheimer's disease (AD) brains, impacting genes and pathways linked to neuronal death. This finding offers new insights into AD pathogenesis.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • MicroRNAs (miRNAs) are key regulatory elements, with a significant proportion found in the brain.
  • miRNAs play critical roles in the development and progression of Alzheimer's disease (AD).

Purpose of the Study:

  • To comprehensively evaluate miRNA expression levels in post-mortem brain (PMB) samples from individuals with and without AD.
  • To identify specific miRNAs implicated in the pathophysiology of Alzheimer's disease.

Main Methods:

  • Utilized high-throughput microarray analysis on temporal gyrus PMB samples from AD and control cases.
  • Validated differentially expressed miRNAs using quantitative real-time PCR (qRT-PCR) on independent PMB samples.
  • Employed bioinformatics analyses (KEGG, mirPath v.3) to explore miRNA-gene-pathway interactions.

Main Results:

  • Identified 6 differentially expressed miRNAs: miR-30e_3p, miR-365b_5p, miR-664_3p, miR-1202, miR-4286, and miR-4449.
  • Discovered close interrelationships between 3 miRNAs, 7 target genes (including PTEN), and 11 signaling pathways (including PI3K-AKT).

Conclusions:

  • Dysregulation of specific miRNAs affects genes and pathways crucial to neuronal death mechanisms.
  • These findings suggest that miRNA dysregulation contributes to AD pathogenesis via apoptosis, autophagy, and oxidative damage pathways.

Related Concept Videos